Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)

PHASE3CompletedINTERVENTIONAL

Enrollment

186

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Oral Chronic Graft vs Host Disease

Interventions

DRUG

Budesonide

3 mg TID

DRUG

Placebo

0 mg TID

Trial Locations (2)

The Hebrew University-Hadassah School of Dental Medicine, Department of Oral Medicine, Jerusalem

University of Regensburg, Regensburg